« Return to News | Drug Sponsors

Merck continues plans to cut jobs

Friday, July 15, 2011 10:07 AM

Last year, Merck disclosed plans to save up to $3.5 billion by closing numerous research sites and manufacturing plants and eliminate roughly 15,000 jobs by 2012, or roughly 10% of the total headcount including the thousands of employees who were part of the 2009 acquisition of Schering-Plough. Before that deal, Merck employed about 53,000 people, reported Pharmalot.

By March, Merck had managed to get headcount down to 93,000, which means another 8,000 or so jobs must still go. Sources say the layoff process is expected to accelerate in early August, as the drug maker continues its restructuring plan and looks for additional ways to save money.

That more pink slips will be handed out is hardly surprising, given that Merck telegraphed the cuts a year ago. Numerous departments have been winnowed in recent months, particularly the Merck Research Laboratories, which once led the industry in new discoveries but now struggles to replenish the pipeline.

Merck execs are interested in bringing the headcount down further, sources say, and are continuing to review more operations, including reducing the scale of the research facility that opened in Boston seven years ago. A Merck spokesman, however, declined to comment on any upcoming moves.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.